Evidence map›Paper›PMID 40163119›Full record

ArticleJAMA network open2025

Postpartum Hormonal Contraceptive Use and Risk of Depression.

Søren Vinther Larsen, Brice Ozenne, Anders Pretzmann Mikkelsen, Xiaoqin Liu, Kathrine Bang Madsen, Trine Munk-Olsen, Øjvind Lidegaard, Vibe Gedsø Frokjaer

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Søren Vinther LarsenNeurobiology Research Unit, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Brice OzenneNeurobiology Research Unit, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Anders Pretzmann MikkelsenDepartment of Gynaecology, Fertility and Obstetrics, Juliane Marie Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Xiaoqin LiuNCRR-National Center for Register-Based Research, Aarhus University, Aarhus, Denmark.
Kathrine Bang MadsenNCRR-National Center for Register-Based Research, Aarhus University, Aarhus, Denmark.
Trine Munk-OlsenDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.
Øjvind LidegaardDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Vibe Gedsø FrokjaerNeurobiology Research Unit, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Hormonal contraceptive (HC) use is associated with depression. It is, however, unknown whether this is also true in the postpartum period when women have a heightened depression risk and are routinely offered HC treatment. Objective: To examine whether HC initiation post partum is associated with the development of depression within 12 months post partum. Design, Setting, and Participants: A population-based cohort study based on nationwide Danish register data was conducted including all primiparous women who gave birth from January 1, 1997, through December 31, 2022. Women were excluded if they had depression within 24 months before delivery, multiple births or stillbirth, or a diagnosis of breast cancer or liver tumor. Data analysis was conducted between March 20, 2023, and January 17, 2025. Exposure: Hormonal contraceptive initiation within 12 months post partum was treated as a time-varying exposure. Hormonal contraceptive types were categorized as combined oral contraceptives (COCs), combined nonoral contraceptives (CNOCs), progestogen-only pills (POPs), and progestogen-only nonoral contraceptives (PNOCs). Main Outcomes and Measures: Depression within 12 months post partum, defined as filling an antidepressant prescription or receiving a hospital diagnosis of depression, was the main outcome. Adjusted hazard ratios (AHRs) and average absolute risks of depression within 12 months post partum were estimated using Cox proportional hazards regression and a G-formula estimator. Results: Of 610 038 first-time mothers, 248 274 (40.7%) initiated HCs within 12 months post partum (mean [SD] age, 27.6 [4.3] years for HC users vs 29.6 [4.8] years for nonusers). Hormonal contraceptive initiation was associated with subsequent depression, with an AHR of 1.49 (95% CI, 1.42-1.56) compared with no use, resulting in an increase in the 12-month absolute risk from 1.36% (95% CI, 1.32%-1.39%) to 1.54% (95% CI, 1.50%-1.57%). The AHR for COC was 1.72 (95% CI, 1.63-1.82); CNOC, 1.97 (95% CI, 1.64-2.36); and PNOC, 1.40 (95% CI, 1.25-1.56). Progestogen-only pill exposure was associated with an instantaneously reduced risk in the early study period, but it was increased late post partum. The earlier COCs were initiated post partum the higher the associated rate ratio of depression. Conclusions and Relevance: In this cohort study, HC initiation post partum was associated with an instantaneous increased risk of developing depression. The associated risk was higher the earlier it was initiated post partum, at least for COC. This finding raises the issue of whether the incidence of depression post partum is increased by routine HC initiation after childbirth.

Indexed as

Contraceptives, Oral, HormonalDepressionDepression, PostpartumHormonal ContraceptionPostpartum PeriodAdultCohort StudiesDenmarkFemaleHumansRegistriesRisk FactorsYoung AdultContraceptives, Oral, Hormonal

Identifiers

PMID40163119
PMCPMC11959440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.